D. Price

First name
D.
Middle name
B.
Last name
Price
Chen, S., Miravitlles, M., Rhee, C. K., Pavord, I. D., Jones, R., Carter, V., et al. (2022). Patients with Chronic Obstructive Pulmonary Disease and Evidence of Eosinophilic Inflammation Experience Exacerbations Despite Receiving Maximal Inhaled Maintenance Therapy. Int J Chron Obstruct Pulmon Dis, 17, 2187-2200. http://doi.org/10.2147/copd.s378649
Heatley, H., Tran, T. N., Bourdin, A., Menzies-Gow, A., Jackson, D. J., Maslova, E., et al. (2022). Observational UK cohort study to describe intermittent oral corticosteroid prescribing patterns and their association with adverse outcomes in asthma. Thorax. http://doi.org/10.1136/thorax-2022-219642
Tran, T. N., Kerkhof, M., Carter, V., & Price, D. B. (2021). Persistence of Eosinophilic Asthma Endotype and Clinical Outcomes: A Real-World Observational Study. J Asthma Allergy, 14, 727-742. http://doi.org/10.2147/jaa.s306416
Turner, S., Richardson, K., Murray, C., Thomas, M., Hillyer, E. V., Burden, A., & Price, D. B. (2017). Long-Acting beta-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2016.06.009
Murray, C. S., Thomas, M., Richardson, K., Price, D. B., & Turner, S. W. (2017). Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study. J Allergy Clin Immunol Pract. http://doi.org/10.1016/j.jaip.2016.12.028
Dollerup, J., Vestbo, J., Murray-Thomas, T., Kaplan, A., Martin, R. J., Pizzichini, E., et al. (2017). Cardiovascular risks in smokers treated with nicotine replacement therapy: a historical cohort study. Clin Epidemiol. http://doi.org/10.2147/clep.s127775
Voorham, J., Roche, N., Benhaddi, H., van der Tol, M., Carter, V., van Boven, J. F. M., et al. (2018). Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK. BMJ Open. http://doi.org/10.1136/bmjopen-2018-022051
Kerkhof, M., Tran, T. N., Soriano, J. B., Golam, S., Gibson, D., Hillyer, E. V., & Price, D. B. (2018). Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population. Thorax. http://doi.org/10.1136/thoraxjnl-2017-210531
Kerkhof, M., Tran, T. N., van den Berge, M., Brusselle, G. G., Gopalan, G., Jones, R. C. M., et al. (2018). Association between blood eosinophil count and risk of readmission for patients with asthma: Historical cohort study. PLoS One. http://doi.org/10.1371/journal.pone.0201143
Turner, S. W., Murray, C., Thomas, M., Burden, A., & Price, D. B. (2018). Applying UK real-world primary care data to predict asthma attacks in 3776 well-characterised children: a retrospective cohort study. NPJ Prim Care Respir Med. http://doi.org/10.1038/s41533-018-0095-5